TIOCONAZOLE

TIOCONAZOLE was reported 1541 times

TIOCONAZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHEMICAL BURN OF GENITALIA 29 0.2377
1 VULVOVAGINAL SWELLING 295 0.1614
2 VULVOVAGINAL EXFOLIATION 8 0.1538
3 BLOOD GLUCAGON ABNORMAL 1 0.1250
4 VULVOVAGINAL BURNING SENSATION 526 0.0861
5 ADMINISTRATION SITE PARAESTHESIA 1 0.0667
6 VULVOVAGINAL ERYTHEMA 52 0.0622
7 VAGINAL EXFOLIATION 3 0.0577
8 INFLUENZA A VIRUS TEST 1 0.0556
9 VULVOVAGINAL HYPOAESTHESIA 1 0.0500
10 VULVAL ERYTHEMA 1 0.0476
11 VULVOVAGINAL PAIN 229 0.0475
12 VULVOVAGINAL ULCERATION 2 0.0408
13 VULVOVAGINAL PRURITUS 197 0.0389
14 VULVOVAGINAL DISCOMFORT 161 0.0364
15 VAGINAL MUCOSAL BLISTERING 8 0.0356
16 VULVOVAGINAL INFLAMMATION 15 0.0325
17 TISSUE IRRITATION 1 0.0303
18 GENITAL PARAESTHESIA 8 0.0276
19 HAEMORRHAGIC URTICARIA 1 0.0250
20 VAGINAL MYCOSIS 5 0.0215
21 VULVOVAGINAL RASH 9 0.0204
22 VAGINITIS 1 0.0204
23 GASTROINTESTINAL TELANGIECTASIA 1 0.0196
24 GENITAL BLISTER 5 0.0181
25 SECOND DEGREE CHEMICAL BURN OF SKIN 1 0.0167
26 LABIA ENLARGED 1 0.0159
27 VULVOVAGINAL INJURY 9 0.0158
28 GENITAL DISCOLOURATION 1 0.0147
29 VAGINAL EROSION 2 0.0128
30 REDUCED BLADDER CAPACITY 1 0.0112
31 VAGINAL SWELLING 4 0.0112
32 VAGINAL INFLAMMATION 2 0.0090
33 CHEMICAL BURN 10 0.0087
34 VAGINAL ODOUR 10 0.0079
35 GENITAL INJURY 1 0.0075
36 VAGINAL CONTRACEPTIVE DEVICE EXPELLED 1 0.0071
37 ENLARGED CLITORIS 1 0.0061
38 VAGINAL DISCHARGE 59 0.0058
39 LUPUS VULGARIS 6 0.0048
40 VAGINAL LACERATION 1 0.0046
41 THERAPEUTIC PRODUCT CROSS-REACTIVITY 4 0.0045
42 ERYTHEMA INFECTIOSUM 1 0.0039
43 BACTERIAL VULVOVAGINITIS 1 0.0035
44 VULVOVAGINITIS 1 0.0034
45 OEDEMA GENITAL 2 0.0031
46 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 2 0.0030
47 RETINITIS 5 0.0029
48 APPLICATION SITE PUSTULES 1 0.0027
49 SKIN ULCER HAEMORRHAGE 1 0.0026
50 VULVAL OEDEMA 1 0.0025
51 CHEMICAL INJURY 2 0.0024
52 VAGINAL ULCERATION 1 0.0024
53 PARVOVIRUS B19 INFECTION 2 0.0022
54 SKIN INDENTATION 1 0.0021
55 VULVOVAGINAL DRYNESS 6 0.0019
56 SERONEGATIVE ARTHRITIS 2 0.0017
57 HAEMORRHAGIC OVARIAN CYST 1 0.0017
58 BONE EROSION 6 0.0017
59 LYMPHATIC DISORDER 1 0.0017
60 APPLICATION SITE WARMTH 2 0.0016
61 HYPERCHOLESTEROLAEMIA 15 0.0016
62 VULVAL DISORDER 1 0.0015
63 HELICOBACTER INFECTION 15 0.0015
64 BRAIN CONTUSION 1 0.0014
65 GENITAL PAIN 2 0.0014
66 MEDICAL DEVICE DISCOMFORT 4 0.0013
67 GENITAL ULCERATION 1 0.0013
68 VAGINAL HAEMORRHAGE 54 0.0012
69 CRANIOSYNOSTOSIS 1 0.0012
70 CLEFT LIP 1 0.0011
71 THERAPEUTIC PRODUCT EFFECT DELAYED 5 0.0011
72 TRAUMATIC INTRACRANIAL HAEMORRHAGE 1 0.0011
73 DEEP VEIN THROMBOSIS POSTOPERATIVE 2 0.0010
74 FOREIGN BODY 4 0.0010
75 STOMA COMPLICATION 1 0.0010
76 GENITAL HYPOAESTHESIA 1 0.0010
77 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 2 0.0010
78 APPLICATION SITE PAPULES 1 0.0009
79 ALLERGY TO ANIMAL 1 0.0009
80 DISLOCATION OF VERTEBRA 2 0.0009
81 APPLICATION SITE SWELLING 4 0.0008
82 CONDITION AGGRAVATED 226 0.0007
83 UNDERDOSE 54 0.0007
84 APPLICATION SITE HAEMORRHAGE 2 0.0007
85 MAST CELL ACTIVATION SYNDROME 1 0.0007
86 DRUG EFFECT LESS THAN EXPECTED 10 0.0007
87 LUPUS-LIKE SYNDROME 6 0.0007
88 EXOSTOSIS 6 0.0007
89 RUBBER SENSITIVITY 1 0.0007
90 BACTERIAL VAGINOSIS 1 0.0006
91 VAGINAL INFECTION 3 0.0006
92 EXPIRED PRODUCT ADMINISTERED 21 0.0006
93 VIRAL UPPER RESPIRATORY TRACT INFECTION 3 0.0006
94 SWOLLEN JOINT COUNT INCREASED 2 0.0006
95 FIBROMYALGIA 15 0.0006
96 DERMATITIS CONTACT 7 0.0006
97 POLYMENORRHOEA 2 0.0006
98 INFUSION SITE DISCHARGE 1 0.0006
99 BURNS SECOND DEGREE 1 0.0006
100 JOINT DISLOCATION 6 0.0006
101 RED BLOOD CELL SEDIMENTATION RATE INCREASED 6 0.0005
102 FOOT DEFORMITY 6 0.0005
103 DYSURIA 19 0.0005
104 HYPERAEMIA 1 0.0005
105 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
106 CHANGE OF BOWEL HABIT 1 0.0005
107 APPLICATION SITE EXFOLIATION 2 0.0005
108 APPLICATION SITE SCAB 1 0.0005
109 INFUSION SITE BRUISING 1 0.0005
110 RHEUMATIC FEVER 2 0.0004
111 FOREIGN BODY IN REPRODUCTIVE TRACT 4 0.0004
112 TYPE 2 DIABETES MELLITUS 15 0.0004
113 BLOOD LOSS ANAEMIA 1 0.0004
114 DYSPAREUNIA 2 0.0004
115 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 1 0.0004
116 LYMPHADENITIS 1 0.0004
117 C-REACTIVE PROTEIN INCREASED 15 0.0004
118 PRODUCT ADMINISTRATION ERROR 8 0.0004
119 CHEMICAL BURN OF SKIN 1 0.0004
120 URINE OUTPUT INCREASED 1 0.0004
121 OSTEOARTHRITIS 15 0.0004
122 RHEUMATOID FACTOR POSITIVE 2 0.0003
123 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
124 DRUG INEFFECTIVE 441 0.0003
125 BLOOD CHOLESTEROL INCREASED 15 0.0003
126 HEPATIC CIRRHOSIS 6 0.0003
127 APPLICATION SITE PAIN 7 0.0003
128 PRESCRIBED OVERDOSE 6 0.0003
129 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 22 0.0003
130 INFUSION SITE HAEMORRHAGE 1 0.0003
131 WALKING AID USER 2 0.0003
132 HYPERSENSITIVITY 53 0.0003
133 NECROTISING FASCIITIS 1 0.0003
134 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2 0.0003
135 AMYLASE INCREASED 1 0.0003
136 DUODENAL ULCER PERFORATION 2 0.0003
137 DEVICE FAILURE 4 0.0003
138 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
139 EXPOSURE VIA BREAST MILK 1 0.0003
140 OBSTRUCTION 1 0.0003
141 DRUG EFFECT INCOMPLETE 9 0.0002
142 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
143 INFUSION RELATED REACTION 16 0.0002
144 MUSCLE INJURY 2 0.0002
145 JOINT STIFFNESS 6 0.0002
146 GRIP STRENGTH DECREASED 2 0.0002
147 BLOOD CREATINE INCREASED 1 0.0002
148 EAR INFECTION 6 0.0002
149 HEPATIC ENZYME INCREASED 15 0.0002
150 BREAST CANCER STAGE I 2 0.0002
151 ROSACEA 1 0.0002
152 SWELLING 20 0.0002
153 MOBILITY DECREASED 15 0.0002
154 AUTOIMMUNE DISORDER 2 0.0002
155 APPLICATION SITE BURN 1 0.0002
156 FLUID INTAKE REDUCED 1 0.0002
157 PHLEBITIS 1 0.0002
158 INTENTIONAL PRODUCT USE ISSUE 17 0.0002
159 TENDERNESS 2 0.0002
160 FOLLICULITIS 2 0.0002
161 ANORECTAL DISCOMFORT 1 0.0002
162 PRODUCT RESIDUE PRESENT 1 0.0002
163 WOUND INFECTION 2 0.0002
164 ABORTION SPONTANEOUS 7 0.0002
165 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
166 ADVERSE DRUG REACTION 15 0.0002
167 PEMPHIGUS 2 0.0002
168 DERMATITIS ALLERGIC 2 0.0002
169 DRUG INTOLERANCE 15 0.0002
170 APPLICATION SITE VESICLES 1 0.0002
171 HAND DEFORMITY 2 0.0002
172 JOINT RANGE OF MOTION DECREASED 2 0.0001
173 WRONG PRODUCT ADMINISTERED 1 0.0001
174 OSTEOPOROSIS 6 0.0001
175 APPLICATION SITE RASH 2 0.0001
176 APPLICATION SITE REACTION 1 0.0001
177 LIVER FUNCTION TEST INCREASED 3 0.0001
178 HYDRONEPHROSIS 1 0.0001
179 BREAST TENDERNESS 1 0.0001
180 HIP ARTHROPLASTY 2 0.0001
181 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
182 GENERAL PHYSICAL HEALTH DETERIORATION 15 0.0001
183 CONGENITAL ANOMALY 1 0.0001
184 CONCUSSION 1 0.0001
185 MULTIPLE ALLERGIES 1 0.0001
186 SCIATICA 2 0.0001
187 POST PROCEDURAL INFECTION 1 0.0001
188 LIVER INJURY 3 0.0001
189 ABNORMAL FAECES 1 0.0001
190 HYPERAESTHESIA 1 0.0001
191 SPINAL COMPRESSION FRACTURE 1 0.0001
192 FUNGAL INFECTION 4 0.0001
193 PERICARDITIS 2 0.0001
194 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
195 APPLICATION SITE ERYTHEMA 3 0.0001
196 NAIL DISORDER 1 0.0001
197 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
198 WRONG DRUG ADMINISTERED 1 0.0001
199 SYNOVITIS 2 0.0001
200 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
201 PRODUCT DISTRIBUTION ISSUE 1 0.0001
202 WOUND 3 0.0001
203 PRODUCT PACKAGING ISSUE 1 0.0001
204 PULMONARY FIBROSIS 2 0.0001
205 LOWER LIMB FRACTURE 2 0.0001
206 AFFECT LABILITY 1 0.0001
207 SKIN FISSURES 2 0.0001
208 ABDOMINAL DISCOMFORT 17 0.0001
209 DISABILITY 2 0.0001
210 MATERNAL EXPOSURE DURING PREGNANCY 9 0.0001
211 HYPOAESTHESIA 15 0.0001
212 NEUTROPHIL COUNT INCREASED 1 0.0001
213 INITIAL INSOMNIA 1 0.0001
214 KNEE ARTHROPLASTY 2 0.0001
215 BREAST PAIN 1 0.0001
216 BODY HEIGHT DECREASED 1 0.0001
217 IRRITABLE BOWEL SYNDROME 2 0.0001
218 HEREDITARY ANGIOEDEMA 1 0.0001
219 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
220 SKIN LACERATION 1 0.0001
221 SKIN DISORDER 3 0.0001
222 GAIT INABILITY 3 0.0001
223 GLOSSODYNIA 2 0.0001
224 BLISTER 5 0.0001
225 THERAPY NON-RESPONDER 4 0.0001
226 EYE INFECTION 1 0.0001
227 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
228 MICTURITION URGENCY 1 0.0001
229 ADVERSE EVENT 8 0.0001
230 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
231 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
232 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
233 URTICARIA 14 0.0001
234 NO THERAPEUTIC RESPONSE 1 0.0001
235 EYE SWELLING 3 0.0001
236 ROTATOR CUFF SYNDROME 1 0.0001
237 INFUSION SITE PAIN 1 0.0001
238 RASH GENERALISED 2 0.0001
239 PLATELET COUNT INCREASED 1 0.0001
240 NODULE 1 0.0001
241 ALOPECIA 15 0.0001
242 ARTHRITIS 6 0.0001
243 ADVERSE REACTION 1 0.0001
244 EXTRA DOSE ADMINISTERED 3 0.0001
245 DECREASED APPETITE 17 0.0001
246 ABDOMINAL PAIN 17 0.0001
247 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
248 BURNING SENSATION 5 0.0001
249 SKIN REACTION 1 0.0001
250 HYPERTENSION 15 0.0001
251 SEASONAL ALLERGY 1 0.0001
252 PRODUCT USE IN UNAPPROVED INDICATION 17 0.0001
253 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
254 DRUG ADMINISTRATION ERROR 2 0.0001
255 EXPOSURE DURING PREGNANCY 4 0.0001
256 PRODUCT USE COMPLAINT 1 0.0001
257 IMPAIRED HEALING 2 0.0001
258 CHILLS 7 0.0001
259 FACE OEDEMA 1 0.0001
260 METRORRHAGIA 1 0.0001
261 ABDOMINAL PAIN UPPER 12 0.0001
262 DELIRIUM 2 0.0001
263 DEVICE USE ISSUE 1 0.0001
264 SLEEP DISORDER 4 0.0001
265 VISUAL IMPAIRMENT 7 0.0001
266 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
267 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
268 PELVIC PAIN 1 0.0001
269 RESTLESS LEGS SYNDROME 1 0.0001
270 BACTERIAL INFECTION 1 0.0001
271 MIDDLE INSOMNIA 1 0.0001
272 BLOOD URINE PRESENT 1 0.0001
273 ACUTE RESPIRATORY FAILURE 1 0.0001
274 HAEMORRHOIDS 1 0.0001
275 BLOOD PRESSURE ABNORMAL 1 0.0001
276 PRESCRIBED UNDERDOSE 1 0.0001
277 PRODUCT PHYSICAL ISSUE 1 0.0000
278 PSORIATIC ARTHROPATHY 2 0.0000
279 OEDEMA PERIPHERAL 6 0.0000
280 DISCOMFORT 3 0.0000
281 POLLAKIURIA 2 0.0000
282 ROAD TRAFFIC ACCIDENT 2 0.0000
283 EATING DISORDER 1 0.0000
284 IMPAIRED WORK ABILITY 1 0.0000
285 POOR QUALITY SLEEP 1 0.0000
286 PRURITUS GENERALISED 1 0.0000
287 AMNESIA 3 0.0000
288 INTENTIONAL PRODUCT MISUSE 4 0.0000
289 FEBRILE NEUTROPENIA 3 0.0000
290 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
291 CHROMATURIA 1 0.0000
292 SKIN DISCOLOURATION 2 0.0000
293 SHOCK 1 0.0000
294 ARTHRALGIA 18 0.0000
295 CHEST PAIN 8 0.0000
296 INJURY 3 0.0000
297 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
298 PRESYNCOPE 1 0.0000
299 OFF LABEL USE 36 0.0000
300 CEREBRAL INFARCTION 1 0.0000
301 OSTEONECROSIS OF JAW 1 0.0000
302 ABDOMINAL PAIN LOWER 1 0.0000
303 PRODUCT COMPLAINT 1 0.0000
304 INFLAMMATION 2 0.0000
305 EXPOSURE VIA SKIN CONTACT 1 0.0000
306 VOMITING 18 0.0000
307 HEADACHE 24 0.0000
308 DIZZINESS 19 0.0000
309 DRUG EFFECT DECREASED 2 0.0000
310 THROAT TIGHTNESS 1 0.0000
311 OEDEMA 2 0.0000
312 LIMB INJURY 1 0.0000
313 ARTHROPATHY 2 0.0000
314 SKIN EXFOLIATION 3 0.0000
315 FLATULENCE 2 0.0000
316 URINARY TRACT INFECTION 6 0.0000
317 MUSCULOSKELETAL STIFFNESS 3 0.0000
318 WHEEZING 2 0.0000
319 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
320 FEELING HOT 2 0.0000
321 RASH 14 0.0000
322 VIRAL INFECTION 1 0.0000
323 LIP SWELLING 1 0.0000
324 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
325 PAIN 18 0.0000
326 SINUSITIS 3 0.0000
327 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
328 ABDOMINAL DISTENSION 3 0.0000
329 RASH MACULAR 1 0.0000
330 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
331 CEREBRAL HAEMORRHAGE 1 0.0000
332 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
333 CRYING 1 0.0000
334 PANIC ATTACK 1 0.0000
335 BRONCHITIS 2 0.0000
336 DYSGEUSIA 2 0.0000
337 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
338 NAUSEA 20 0.0000
339 JOINT SWELLING 3 0.0000
340 PNEUMONIA 8 0.0000
341 FATIGUE 19 0.0000
342 INFLUENZA LIKE ILLNESS 2 0.0000
343 PAIN IN EXTREMITY 7 0.0000
344 PRURITUS 9 0.0000
345 SEPTIC SHOCK 1 0.0000
346 INSOMNIA 6 0.0000
347 TACHYCARDIA 2 0.0000
348 THROAT IRRITATION 1 0.0000
349 SKIN IRRITATION 1 0.0000
350 HYPOKALAEMIA 1 0.0000
351 OROPHARYNGEAL PAIN 2 0.0000
352 COGNITIVE DISORDER 1 0.0000
353 DYSPHAGIA 2 0.0000
354 MIGRAINE 2 0.0000
355 GAIT DISTURBANCE 4 0.0000
356 CONTUSION 2 0.0000
357 SYNCOPE 2 0.0000
358 CELLULITIS 1 0.0000
359 THERAPY CESSATION 1 0.0000
360 PERIPHERAL SWELLING 3 0.0000
361 PANCREATITIS 1 0.0000
362 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
363 ANAPHYLACTIC REACTION 1 0.0000
364 HYPONATRAEMIA 1 0.0000
365 ASTHMA 2 0.0000
366 RHEUMATOID ARTHRITIS 2 0.0000
367 MUSCULAR WEAKNESS 2 0.0000
368 ANXIETY 5 0.0000
369 LETHARGY 1 0.0000
370 EYE IRRITATION 1 0.0000
371 PRODUCT SUBSTITUTION ISSUE 1 0.0000
372 PYREXIA 6 0.0000
373 PALPITATIONS 2 0.0000
374 THERAPEUTIC RESPONSE DECREASED 1 0.0000
375 MUSCLE SPASMS 3 0.0000
376 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
377 MALAISE 7 0.0000
378 HYPERHIDROSIS 2 0.0000
379 PSORIASIS 2 0.0000
380 INJECTION SITE PRURITUS 1 0.0000
381 MEMORY IMPAIRMENT 2 0.0000
382 WEIGHT DECREASED 4 0.0000
383 INFECTION 2 0.0000
384 CONSTIPATION 3 0.0000
385 WEIGHT INCREASED 3 0.0000
386 ACNE 1 0.0000
387 INJECTION SITE SWELLING 1 0.0000
388 BACK PAIN 3 0.0000
389 DRUG INTERACTION 2 0.0000
390 THROMBOSIS 1 0.0000
391 CONFUSIONAL STATE 2 0.0000
392 DYSPNOEA 7 0.0000
393 DRY MOUTH 1 0.0000
394 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
395 RENAL IMPAIRMENT 1 0.0000
396 COVID-19 2 0.0000
397 NASOPHARYNGITIS 2 0.0000
398 DYSPEPSIA 1 0.0000
399 ILLNESS 1 0.0000
400 DEPRESSION 2 0.0000
401 INJECTION SITE ERYTHEMA 1 0.0000
402 LOSS OF CONSCIOUSNESS 1 0.0000
403 DIARRHOEA 5 0.0000
404 RENAL FAILURE 1 0.0000
405 DRY SKIN 1 0.0000
406 PRODUCT QUALITY ISSUE 1 0.0000
407 PRODUCT DOSE OMISSION ISSUE 2 0.0000
408 BLOOD PRESSURE INCREASED 1 0.0000
409 HOSPITALISATION 1 0.0000
410 PARAESTHESIA 1 0.0000
411 DRUG DEPENDENCE 1 0.0000
412 TREMOR 1 0.0000
413 CEREBROVASCULAR ACCIDENT 1 0.0000
414 MYALGIA 1 0.0000
415 NO ADVERSE EVENT 1 0.0000
416 PRODUCT USE ISSUE 1 0.0000
417 ASTHENIA 2 0.0000
418 ANAEMIA 1 0.0000
419 SOMNOLENCE 1 0.0000
420 ERYTHEMA 1 0.0000
421 INCORRECT DOSE ADMINISTERED 1 0.0000
422 FEELING ABNORMAL 1 0.0000
423 INJECTION SITE PAIN 1 0.0000
424 FALL 1 0.0000
425 DEATH 2 0.0000